Pfizer India Q1 profit falls 83% to Rs 33 crore, revenue down 21%
The drug firm said exceptional items for June quarter comprised Rs 130 crore on account of a voluntary retirement scheme and Rs 6 crore for restructuring to drive business transformation.
PFIZER LTD. - 500680 - Pfizer Limited - Important Communication For Shareholders - 71St Annual General Meeting And Payment Of Dividend.
Pfizer Limited - Important Communication for Shareholders - 71st Annual General Meeting and Payment of Dividend. PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Limited has received a request for issue of duplicate Share Certificate(s) from Shareholder(s) PFIZER LTD. - 500680 - Board Meeting Outcome for Pfizer Limited - Unaudited Financial Results For The Quarter Ended June 30, 2022.
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the unaudited financial results for the quarter ended June 30, 2022, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 12:00 noon and concluded at 2:45 p.m. Also please find enclosed the Limited Review Report by our Auditors M/s. Walker Chandiok & Co LLP, in respect of the above results. PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pfizer Limited - Newspaper Advertisement for 71st AGM, e-voting facility and Record date. PFIZER LTD. - 500680 - This Is To Inform You That The Record Date For The Payment Of Dividend Of Rs. 35 (350%) Per Equity Share Is Friday, August 19, 2022.
This is to inform you that the Record Date for the payment of Dividend of Rs. 35 (350%) per equity share is Friday, August 19, 2022. PFIZER LTD. - 500680 - Reg. 34 (1) Annual Report.
This is to inform you that the 71st Annual General Meeting ('AGM') of the Company is scheduled to be held on Friday, August 26, 2022 at 3:00 p.m. (IST) through Video Conferencing (''VC'') / Other Audio-Visual Means ('OAVM') in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. We hereby enclose a copy of the Annual Report of the Company for the Financial Year ended March 31, 2022, for your reference. PFIZER LTD. - 500680 - Pfizer Limited Annual General Meeting On Friday, August 26, 2022 And Record Date Intimation
This is to inform you that the 71st Annual General Meeting ('AGM') of the Company is scheduled to be held on Friday, August 26, 2022 at 3:00 p.m. (IST) through Video Conferencing (''VC'') / Other Audio-Visual Means ('OAVM') in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. We hereby enclose a copy of the Annual Report of the Company for the Financial Year ended March 31, 2022, for your reference. PFIZER LTD. - 500680 - Update On Sale Of Pfizer Limited'S Upjohn Business To Mylan Pharmaceuticals Private Limited.
The Company had vide its letter dated October 1, 2021, informed you that it had entered into a business transfer agreement ('BTA') with Mylan Pharmaceuticals Private Limited to transfer certain primarily off-patent branded and generic established medicines business ('Upjohn Business') as a going concern to Mylan for a consideration of INR 180.48 crore. Further, the completion of the said transaction was subject to fulfilment of certain conditions as set out in the BTA. In that regard, please note that Mylan has received the requisite regulatory approvals and both the parties have completed the conditions precedents set out in the BTA. Accordingly, the Company has received the purchase consideration of INR 180.48 Crore from Mylan and the Company has transferred its Upjohn Business comprising of six brands which included Lyrica, Viagra, Celebrex, Amlogard, Daxid and Dilantin along with related business assets and liabilities to Mylan, effective August 1, 2022. PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Limited has received requests for issue of duplicate Share Certificate(s) from the Shareholder(s).